| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Connect Biopharma Holdings Ltd is a clinical-stage biopharmaceutical company dedicated to transforming care for asthma and chronic obstructive pulmonary disease (COPD). The company is advancing rademikibart, a next-generation antibody designed to...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Connect Biopharma Hldgs (NASDAQ:CNTB) through any online brokerage.
Other companies in Connect Biopharma Hldgs’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Connect Biopharma Hldgs has a consensus price target of $6.38.
The stock price for Connect Biopharma Hldgs (NASDAQ: CNTB) is $1.1 last updated September 30, 2026 at 7:59 PM EDT.
There are no upcoming dividends for Connect Biopharma Hldgs.
Connect Biopharma Hldgs does not have any upcoming earnings scheduled.
There is no upcoming split for Connect Biopharma Hldgs.
Connect Biopharma Hldgs is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
